Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vilber is a private French life science tools company that designs, manufactures, and commercializes imaging systems for laboratory and preclinical research applications. Its portfolio spans Western blot and chemiluminescence imaging, DNA/RNA gel documentation, UV instrumentation, and in vivo preclinical imaging including NIR-II fluorescence and bioluminescence systems. The company serves pharmaceutical and biotechnology companies, universities, medical centers, and government research institutes through a global distributor and subsidiary network. Vilber positions itself as a specialist in molecular imaging and analysis rather than a therapeutic drug developer, with commercially available instruments and software used in research workflows worldwide. Its business is centered on enabling research, quantification, and visualization in protein, nucleic acid, and small-animal imaging applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vilber.